Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence

Clinical trial NCT05412966 · COMPLETED

Trial details

NCT number: NCT05412966
Sponsor: Pear Therapeutics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Opioid Use Disorder

Start date: 2022-11-04
Primary completion: 2022-11-23
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.